Spinocerebellar ataxia type 2, often shortened to SCA2, is a rare autosomal dominant disorder caused by an expansion of a CAG trinucleotide repeat in the ATXN2 gene. It usually begins around the age of 40. Symptoms include difficulty articulating speech, dysmetria, ataxia, supranuclear ophthalmoplegia with slow saccadic eye movements, and peripheral neuropathy with reduced vibration sense and reduced or absent ankle and knee reflexes. Perioral spasm, head tremor and cramps are also common, and about a quarter of patients show pyramidal signs such as a Babinski sign and increased muscle tone. Average life expectancy is given as 11 years. The disorder is common in India and Cuba, especially in the Cuban province of Holguin, where incidence is about 4 in every 10,000 people.
Facts
Classification
ICD-10 ChapterVI: Diseases of the Nervous System 1 Communicable or Non-communicable Causative Agent
Causative Agent (category) Prevalence Band Sources
1. Spinocerebellar ataxia type 2 (Wikipedia)
Lead, first sentence
caused by a (CAG)n trinucleotide expansion in a gene ATXN2
Lead, symptoms
difficulty articulating speech, dysmetria, ataxia, supranuclear ophthalmoplegia
lead sentence 1
Spinocerebellar ataxia type 2 (SCA2) is a rare autosomal dominant disorder caused by a (CAG)n trinucleotide expansion in a gene ATXN2.
Lead: disease category
Spinocerebellar ataxia type 2 (SCA2) is a rare autosomal dominant disorder caused by a (CAG)n trinucleotide expansion in a gene ATXN2.
View the Source2. Orphadata (Orphanet): Orphadata epidemiology for ORPHA:98756 Spinocerebellar ataxia type 2
Orphadata (Orphanet)Prevalence, WorldwideQuote, Prevalence, Worldwide
"PrevalenceClass": "1-9 / 100 000", "PrevalenceGeographic": "Worldwide"
View the Source Reader Challenges (0)
No disputes yet. Spotted an error or a better source? Open the first one.
Sign in to dispute this or suggest a correction.